That is necessary, because the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and be reliable. In other words, we need to understand how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental procedure (jeff brown latest prediction). Now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're created to do. This was an advancement practically no one saw. But it's going to have profound implications for curing illness. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be lots of financial investment opportunities in this area, too. Shifting subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown). That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it pulled back possibly considerably prior to going higher - biotech stocks. I've been covering bitcoin for a long period of time now. Among the first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were mostly informing readers. But that's not the huge question anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a trusted 170-year-old institution. So consider that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. legacy report prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are so many terrific personal business on the verge of hitting the public markets And I've been working on a new method for you to invest even prior to these companies go public.
This chance has been constructing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to find out all the information. Go right here to reserve your spot totally free.
Emma Walsh here, managing editor of the Journal. Regular Journal readers understand that tech isn't our normal beat (jeff bezos). And when it concerns tech investing, we leave it to the professionals. The good news is, we have several such specialists in our Rolodex. Our coworker Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing experts we understand (future report review). In fact, he had several triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the huge photo and anticipate what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing rapid development and developing incredible opportunities for investors. I desire to make sure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. jeff brown genetic sequencing stock. However despite what lots of readers may believe, this is a pattern that's simply starting. Although the COVID-19 pandemic disrupted supply chains in 2015, a remarkable 250 million 5G-enabled gadgets were still offered.
And all of this ultimately resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by two months (bleeding edge). Losing two months of production and sales truly affects how lots of 5G gadgets are offered in the fiscal year. When you consider all of that, selling 250 million systems is remarkable. More significantly, the hold-ups triggered by the pandemic produced a heap of pent-up demand. Which demand is now going to be pushed into 2021. In fact, I predict that more than 500 million 5G gadgets will be shipped in 2021 - jeff brown 2021 predictions. And that's not my only 5G prediction When I've spoken about 5G in the past, I've explained its three various stages.
In Phase Two, 5G devices go on sale. 5G phones and other items start to reach consumers. And in Phase Three, 5G services start to be used (jeff brown top biotech stock 2021). That's when we start to see applications working on 5G networks. Consider things like massive multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will start Stage 3 by this summer season. This begins something of a virtuous cycle: Many people do not really care about the technology. But they will care if there are amazing applications that can only be accessed with a 5G phone.
That results in more 5G apps being developed. In reality, 5G is going to open a suite of amazing applications: self-driving vehicles, the Internet of Things, robotic surgical treatment, and more. All of these technologies require 5G. The investment opportunities going forward will be enormous. Stepping far from 5G, the next crucial technology I anticipate in 2021 is CRISPR genetic editing. CRISPR means "clustered frequently interspaced short palindromic repeat." It's a mouthful. However it's one of the most interesting advancements in biotechnology. At a high level, CRISPR is an innovation that can edit our hereditary makeup as if it were software.
The program can crash or not operate correctly. CRISPR uses a comparable idea however with our genetic code. "Typos" in our genome can result in disease. CRISPR can fix these "typos." For several years, CRISPR was mostly a specific niche technology that wasn't well comprehended. And throughout that time, there were really just three business running in this space. However things are altering. CRISPR is no longer just theoretical. We're seeing real results. We're treating illness and seeing that this technology simply works. And as a result, a "2nd crop" of early-stage CRISPR companies is going public and delivering amazing returns. This entire market is effectively a greenfield opportunity.
There's space for lots of companies to exist in this space. first lady. And there will be more. That's my forecast for CRISPR in 2021. I predict that 2 or 3 more genetic editing business will hold their IPOs. Sticking with biotechnology, we are seeing incredible things happening at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its latest Alpha, Fold software application can precisely predict the folding of a protein based exclusively on its amino acid sequence with 92. 4% accuracy. That is necessary since the method a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and be reliable.
Historically, this has been a trial-and-error process. But now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much simpler to develop drugs that do what they're developed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one however several drug therapies produced using this technology. This was one of those developments that almost no one saw. But it's going to have profound implications for curing illness. And, obviously, there will be plenty of investment opportunities in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it drew back possibly substantially before going higher. I've been covering bitcoin for a long period of time now. One of the first research study reports I ever published was on bitcoin - jeff brown 1 biotech. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my recommendation. But at the time of that preliminary recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
But no one is asking that concern anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. brownstone research stock. Mass, Mutual is a 150-year-old institution. So believe about that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another reward prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the details depends on date since February 2021, however we might not individually confirm this claim. Offered Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down an exact figure at this moment. Brown is best understood for his sage-like ability to choose winning technology stocks. He invested more than 25 years investigating innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an excellent point of view on the market. He's constantly on the hunt for new chances, and he shares much of his best picks in the Near Future Report.
That's high appreciation, however it's not absurdly reasoned. Brown has an exceptional track record as a stock-picker, and he effectively anticipated a few of the most significant economic events of the previous 20 years. Although he doesn't appear to release his picks to the public, the service's success is a direct indication of Brown's stock-picking prowess. Nobody on Wall Street gets it right each time, however Jeff Brown's accurate forecasts have actually earned him legions of devoted followers. That says a lot about his ability. The Near Future Report is published by Brownstone Research study, a popular monetary research study publisher. Brownstone Research study uses a number of research study services with a variety of expertises - jeff brown predictions for 2021.
The company is also connected with Bonner & Partners, another well-respected research study publisher - exponential growth. On its website, Brownstone states its objective is to supply retail investors with professional-grade research: "For too long, the best investment research study has actually not been readily available to private investors. It has actually been generally booked for investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown biotech stock. The objective of Brownstone Research is to make that sort of proprietary research study offered to any investors seeking to get an edge in the markets. The objective is basic to deliver special and rewarding investment research study discovered nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise works as the company's Chief Investment Analyst.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After decades of constant success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout many of America. If you understand even a bit about the marketplace, you understand that he has a credibility as a King Midas of sorts. united states. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big project.
In truth, Brown believes S.A.V. last year. could be "the most significant pattern of the 2020s, and he's not alone. Inspect out these quotes from other well-known S.A.V. bulls: Elon's next huge act will be marrying two innovative innovations: synthetic intelligence and electrical vehicles. Musk hopes the combination will help him establish the first fully-autonomous, self-driving automobiles ever. It's absolutely nothing except the automobile industry's Holy Grail. As you know, electric automobiles and self-driving cars and truck stocks have actually been big this year, but the Wall Street maker has actually approved hype without much concrete outcome. In spite of a drastic boost in competitors over the past few years, Brown still believes Musk has the best opportunity of putting everything together.
tech might be the magic string that connects all of it together. S.A.V. stands for Shared Autonomous Automobile, and it might be the future of transportation. Generally, this technology would enable you to rent your automobile as a self-governing, self-driving taxi when you're not using it. You simply get out of the vehicle and press a button on an app that tells the vehicle to "join the fleet." Next thing you understand, you're relaxing on your couch while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a large chunk of the earnings. It sounds outrageous, however it could be closed than you believe.